Article
Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous…
OncoTargets and Therapy · 2020 · Zhen H, Li G, Zhao P, Zhang Y, Wang J, Yu J, Cao B
Key facts
| Title | Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways |
|---|---|
| First author | Zhen H, Li G, Zhao P, Zhang Y, Wang J, Yu J, Cao B |
| Journal | OncoTargets and Therapy |
| Published | Dec 1, 2020 |
| DOI | 10.2147/OTT.S276125 |
| Devices mentioned | K181380 |
| Product codes mentioned | MAX |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1